Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Hydergine Tablets*

Hydergine Tablets* :
Type Medicine Non Marketed
Originator B
Agent Khalil Fattal & Fils
Distributor Khalil Fattal & Fils
Laboratory Novartis
Responsible Party Novartis Pharma AG
Origin Switzerland
Manufacturer Novartis Farma SPA
Origin Italy
ATC C04AE01

Your comment will appear shortly after approval

Hydergine Tablets* :

Revision Date : 01/02/2009


Effect Frequency
Bradycardia Rare
Cardiac valve disease Very rare
Cephalea Rare
Diarrhoea (Diarrhea) Rare
Heart valve regurgitation Very rare
Hypotension Rare
Nasal congestion Rare
Nausea Rare
Pericardial effusion Very rare
Pericarditis Very rare
Retroperitoneal fibrosis Very rare
Skin rash Rare
Stomach ache Rare
Vertigo Rare
Vomiting Rare

Different Units By MoH Code

Revision Date : 24/02/2006

Hydergine Tablets*  MoH 829 :
Form Tablet
Package Size Box of 30
Strength 1.5mg
NSSF ✘
Quarantine ✘
Reg. Number 19021
Submission date 01/01/1970
Registration Year 1970
Archived Date 2016


Price Comparison

● Country: KSA
● Package Size: 30
● Public Price: 52.25 SAR ( 1,235,190.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 1,7417 SAR ( 23,640.00 LBP )
● Reference: sfda
● Pricing Date: 05/03/2020
● Type: Medicine Non Marketed

● Country: UK
● Package Size: 100
● Public Price: 12.94 GBP ( 1,470,618.06 LBP )
● Pack size unit used: 100
● Cost/Unit: 0,1294 GBP ( 0.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Withdrawn

● Country: Switzerland
● Package Size: 100
● Public Price: 45 CHF ( 4,653,900.00 LBP )
● Pack size unit used: 100
● Cost/Unit: 0,45 CHF ( 0.00 LBP )
● Exfactory Price: 24.93 CHF
● Pricing Date: 28/10/2017
● Type: Medicine Non Marketed

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info